VN1R83P

Across TCGA pan-cancer cohorts, VN1R83P RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of VN1R83P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where VN1R83P RNA is repressed in tumor relative to normal tissue. In most cancer types VN1R83P is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

THCA, KIRC, and LIHC are the cancer types where VN1R83P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R83P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.930	<.001	8	view →
KIRC	All	All	+0.439	<.001	8	view →
LIHC	All	All	+0.335	<.001	5	view →
LUSC	All	All	−0.470	<.001	3	view →
CHOL	All	All	+1.256	.005	2	view →
READ	All	III,IV	+0.739	.008	2	view →
PRAD	All	All	+0.578	<.001	2	view →
COAD	All	All	+0.443	.009	2	view →
BLCA	Female	IV	+0.859	.011	1	view →
KICH	All	All	+0.492	.021	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

VN1R83P–THCA

Open the THCA breakdown →